TNFSF10 and cholangiocarcinoma: In human CCA cells, forced expression of a constitutively active form of YAP led to decreased expression of TRAIL, resulting in enhanced resistance to Nutlin-3, a chemotherapeutic drug preventing the interaction between p53 and its inhibitor MDM2.